SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SPARC Receives CRL from USFDA for Latanoprost NDA

01 Aug 2015 Evaluate

Sun Pharma Advanced Research Company (SPARC) has received Complete Response letter (CRL) from U.S. Food and Drug Administration (USFDA) to its New Drug Application (NDA) for Xelpros, Latanoprost BAK-free eyedrops. The company has submitted a response to an earlier CRL it had received from the USFDA, wherein no additional preclinical or clinical data was required. While the USFDA has accepted the clarifications and changes to the labeling, company has now received another CRL from the USFDA seeking minor changes to the proposed labeling. The company hopes to address these requirements soon.

This product is to be manufactured at SPIL’s Halol facility and the USFDA has indicated that a satisfactory resolution of the cGMP deficiencies at this facility is a prerequisite for the final approval of Xelpros. SPARC had recently out-licensed this product to a subsidiary of Sun Pharmaceutical Industries (SPIL).

Sun Pharma Advanced Research Company is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Sun Pharma Adv. Res Share Price

143.00 -0.30 (-0.21%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 428.35
Indegene 491.95
CMS Info Systems 312.90
JITF Infralogistics 312.00
Sagility 42.16
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×